Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colloidal silver gelatin sponge is a hemostatic and antibacterial wound dressing composed of a resorbable gelatin matrix impregnated with colloidal ( finely dispersed) silver. It is primarily used in dental and surgical settings to control bleeding ( hemostasis) and prevent wound infections after procedures such as tooth extractions or other oral surgeries. The mechanism of action involves the physical absorption of blood by the porous gelatin structure to promote clot formation and stabilize the coagulum. Simultaneously, the slow release of silver ions from the colloidal silver provides broad-spectrum antibacterial activity throughout the absorption period. This combination accelerates healing by reducing infection risk—including against multidrug-resistant bacteria like MRSA—and supporting tissue regeneration[1][3][4]. The product is fully resorbable and does not require removal[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on colloidal silver gelatin sponge.